Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;32 Suppl 2(Suppl 2):S32-86.
doi: 10.3747/pdi.2011.00091.

Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update

Bradley A Warady  1 , Sevcan Bakkaloglu, Jason Newland, Michelle Cantwell, Enrico Verrina, Alicia Neu, Vimal Chadha, Hui-Kim Yap, Franz Schaefer
Affiliations
Review

Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update

Bradley A Warady et al. Perit Dial Int. 2012 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
— Empiric therapy. a If the center’s rate of methicillin-resistant Staphylococcus aureus (MRSA) exceeds 10%, or if the patient has history of MRSA infection or colonization, glycopeptide (vancomycin or teicoplanin) should be added to cefepime or should replace the first-generation cephalosporin for gram-positive coverage. Glycopeptide use can also be considered if the patient has a history of severe allergy to penicillins and cephalosporins.
Figure 2
Figure 2
— Gram-positive organism on culture. MRSA = methicillin-resistant Staphylococcus aureus; MSSA = methicillin-sensitive S. aureus; VRE = vancomycin-resistant enterococci.
Figure 3
Figure 3
— Gram-negative organism on culture.
See this image and copyright information in PMC

References

    1. Auron A, Simon S, Andrews W, Jones L, Johnson S, Musharaf G, et al. Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol 2007; 22:578–85 - PubMed
    1. The EMMES Corporation North American Pediatric Renal Trials and Collaborative Studies: NAPRTCS 2008 Annual Report. Renal Transplantation, Dialysis, Chronic Renal Insufficiency. Rockville, MD: The EMMES Corporation; 2008. [Available online at: https://web.emmes.com/study/ped/annlrept/Annual%20Report%20-2008.pdf; accessed April 2012]
    1. Warady BA, Schaefer F, Holloway M, Alexander S, Kandert M, Piraino B, et al. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 2000; 20:610–24 - PubMed
    1. Warady BA, Feneberg R, Verrina E, Flynn JT, Müller–Wiefel DE, Besbas N, et al. Peritonitis in children who receive long-term dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 2007; 18:2172–9 - PubMed
    1. Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, et al. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 2007; 72:1374–9 - PubMed

MeSH terms

LinkOut - more resources